Quarterly report pursuant to Section 13 or 15(d)

Net (Loss) Income Per Share (Schedule Of reconciliation of the net income (loss) per basic and diluted common share) (Details)

v3.22.0.1
Net (Loss) Income Per Share (Schedule Of reconciliation of the net income (loss) per basic and diluted common share) (Details) - USD ($)
 3 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Schedule of Earnings Per Share, Basic and Diluted [Line Items]    
Net (loss) income $ (6,380,006) $ 17,227,701
Basic weighted average common shares outstanding 80,023,168 70,313,589
Common stock purchase warrants   1,025,580
Total net effect of dilutive instruments   5,485,448
Diluted weighted average common shares outstanding 80,023,168 75,799,037
Net (loss) income per basic common share outstanding $ (0.08) $ 0.25
Net (loss) income per diluted common share outstanding $ (0.08) $ 0.23
Stock Options [Member]    
Schedule of Earnings Per Share, Basic and Diluted [Line Items]    
Stock options and appreciation rights   4,421,341
Stock Appreciation Rights (SARs) [Member]    
Schedule of Earnings Per Share, Basic and Diluted [Line Items]    
Stock options and appreciation rights   38,527